Oppenheimer Reiterates Outperform on Transcat, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Martin Yang has reiterated an Outperform rating on Transcat (NASDAQ:TRNS) and increased the price target from $120 to $125.
April 18, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Transcat's Outperform rating was reiterated by Oppenheimer, with a price target increase from $120 to $125.
The reiteration of an Outperform rating combined with a raised price target by a reputable analyst like Martin Yang suggests a strong bullish sentiment towards Transcat. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100